Literature DB >> 26573884

Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.

Subhashie Wijemanne1, Joseph Jankovic1, Randolph W Evans2.   

Abstract

Nausea and vomiting are a frequent accompaniment of migraine and anti-nausea medications are frequently used in its management. The majority of anti-nausea medications that are used in migraine are dopamine receptor blocking agents and therefore have the potential to cause drug-induced movement disorders. This article explores the risk of such drug-induced movement disorders in migraineurs who were treated with these medications.
© 2015 American Headache Society.

Entities:  

Keywords:  acute dystonic reaction; akathisia; metoclopramide; migraine; prochlorperazine; promethazine; tardive dyskinesia

Mesh：

Substances：

Year:  2015        PMID： 26573884     DOI： 10.1111/head.12712

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


  10 in total

Review 1.  Medication-Induced Tardive Dyskinesia: A Review and Update.

Authors:  Elyse M Cornett; Matthew Novitch; Alan David Kaye; Vijay Kata; Adam M Kaye
Journal:  Ochsner J       Date:  2017

Review 2.  Tardive Dyskinesia: Treatment Update.

Authors:  Divya Arya; Tarannum Khan; Adam J Margolius; Hubert H Fernandez
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-16       Impact factor: 5.081

3.  Acute Drug-Induced Symptoms of Restless Legs Syndrome in an Emergency Department: What's in a Name?

Authors:  Robert C Stowe
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

4.  Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.

Authors:  Kristian Svendsen; Mollie Wood; Erika Olsson; Hedvig Nordeng
Journal:  Eur J Clin Pharmacol       Date:  2017-12-30       Impact factor: 2.953

Review 5.  Drug Safety in Episodic Migraine Management in Adults Part 1: Acute Treatments.

Authors:  Yulia Y Orlova; Sandhya Mehla; Abigail L Chua
Journal:  Curr Pain Headache Rep       Date:  2022-05-10

Review 6.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

7.  Metoclopramide induced acute dystonic reaction: A case report.

Authors:  Mohamed Sheikh Hassan; Mosab Ahmed Nor
Journal:  Ann Med Surg (Lond)       Date:  2022-01-11

Review 8.  Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?

Authors:  Robert C Gibler; Kaelynn E Knestrick; Brooke L Reidy; Daniel N Lax; Scott W Powers
Journal:  Pediatric Health Med Ther       Date:  2022-09-09

9.  Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report.

Authors:  Shoko Sakamoto; Yasuhiko Deguchi; Sawako Uchida; Yoshiaki Itoh; Koki Inoue
Journal:  Neuropsychopharmacol Rep       Date:  2022-06-18

10.  MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia.

Authors:  Dong Xu; Alexandrea G Ham; Rickey D Tivis; Matthew L Caylor; Aoxiang Tao; Steve T Flynn; Peter J Economen; Hung K Dang; Royal W Johnson; Vaughn L Culbertson
Journal:  EBioMedicine       Date:  2017-11-22       Impact factor: 8.143
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.